Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.85)
# 3,146
Out of 4,944 analysts
173
Total ratings
45.21%
Success rate
-1.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $3 → $4 | $4.24 | -5.66% | 16 | Jul 15, 2025 | |
| MDT Medtronic | Maintains: Overweight | $98 → $107 | $92.08 | +16.20% | 10 | Jul 15, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $160 → $147 | $162.35 | -9.45% | 17 | Jul 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $101.82 | -6.70% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $478.19 | +35.93% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $13.32 | -9.91% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $131.13 | -27.55% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $86.03 | -1.20% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $43.85 | -65.79% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $309.63 | +10.78% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.59 | +780.50% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $23.98 | +100.17% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $76.93 | +32.59% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $102.64 | -43.49% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | - | - | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $80.17 | +63.40% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $131.02 | +1.51% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $376.61 | -41.58% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | - | - | 2 | Feb 25, 2022 |
Sight Sciences
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $3 → $4
Current: $4.24
Upside: -5.66%
Medtronic
Jul 15, 2025
Maintains: Overweight
Price Target: $98 → $107
Current: $92.08
Upside: +16.20%
iRhythm Technologies
Jul 15, 2025
Maintains: Overweight
Price Target: $160 → $147
Current: $162.35
Upside: -9.45%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $101.82
Upside: -6.70%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $478.19
Upside: +35.93%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $13.32
Upside: -9.91%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $131.13
Upside: -27.55%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $86.03
Upside: -1.20%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $43.85
Upside: -65.79%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $309.63
Upside: +10.78%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.59
Upside: +780.50%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $23.98
Upside: +100.17%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $76.93
Upside: +32.59%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $102.64
Upside: -43.49%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: -
Upside: -
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $80.17
Upside: +63.40%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $131.02
Upside: +1.51%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $376.61
Upside: -41.58%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: -
Upside: -